$CVSI News

CV Sciences, Inc. (CVSI) Shareholder/Analyst Call Prepared Remarks Transcript

CV Sciences Inc (CVSI) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

CV Sciences, Inc. (CVSI) Q1 2026 Earnings Call Prepared Remarks Transcript

CV Sciences Reports Q1 2026 Results: Full Earnings Call Transcript

CV Sciences Q1 Sales $3.195M Down From $3.606M YoY

CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026

CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results

CV Sciences, Inc. (CVSI) Q4 2025 Earnings Call Prepared Remarks Transcript

CV Sciences Q4 Sales $3.307M Down From $3.884M YoY.

CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026

CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

CV Sciences Inc (CVSI) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...

CV Sciences, Inc. Reports Third Quarter 2025 Financial Results

CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript

CV Sciences Q3 Sales $3.256M Down From $3.865M YoY

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus